Yes, sleep apnea causes measurable, body-wide inflammation. People with obstructive sleep apnea (OSA) have roughly twice the blood levels of key inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6) compared to people without the condition. This inflammation isn’t a minor side effect. It’s a central mechanism through which sleep apnea damages blood vessels, disrupts metabolism, and may impair brain function over time.
How Interrupted Breathing Triggers Inflammation
The root cause is intermittent hypoxia: the repeated drops in blood oxygen that happen every time your airway collapses during sleep. In a single night, someone with severe sleep apnea can experience dozens of these oxygen dips per hour. Each time oxygen falls and then rebounds, it creates a pattern similar to what happens during a reperfusion injury, where tissue damage occurs not just from the lack of oxygen but from the flood of oxygen returning afterward.
This cycling between low and normal oxygen generates a surge of reactive oxygen species, essentially unstable molecules that damage cells. That oxidative stress activates a specific inflammatory signaling pathway called NF-κB, which acts as a master switch for inflammation. Sustained low oxygen (the kind you’d experience at high altitude, for example) tends to activate a different pathway. But the intermittent pattern unique to sleep apnea preferentially turns on NF-κB-driven inflammation, likely because of the oxidative stress created by repeated reoxygenation. Once NF-κB is active, it ramps up the production of inflammatory proteins throughout the body.
Inflammatory Markers in Sleep Apnea
The inflammation caused by sleep apnea shows up clearly in blood tests. In a study comparing people with OSA to healthy controls, those with sleep apnea had approximately double the concentrations of CRP and IL-6 in their blood. Levels of TNF-alpha, another inflammatory protein involved in immune activation and tissue damage, were 1.3 to 1.5 times higher.
CRP levels also rise in step with disease severity. Data from the European Sleep Apnea Database found a clear dose-response pattern: people with no sleep apnea had a median CRP of 2.0 mg/L, while those with severe sleep apnea (30 or more breathing disruptions per hour) had a median of 3.7 mg/L. CRP above 3.0 mg/L is generally considered elevated and associated with higher cardiovascular risk, so many people with moderate to severe sleep apnea are living with chronically elevated inflammation by this measure.
Damage to Blood Vessel Walls
One of the most consequential effects of this inflammation is what it does to the inner lining of blood vessels, the endothelium. Healthy endothelial cells produce nitric oxide (NO), a molecule that keeps vessels relaxed and flexible. In people with untreated sleep apnea, the enzyme responsible for producing NO is reduced by 59%, and its activated form is reduced by 94%. At the same time, markers of oxidative stress and inflammation in the vessel walls are five times higher than in people without OSA.
This combination is particularly damaging. With less nitric oxide available, blood vessels become stiffer and more prone to constriction. The oxidative stress further degrades whatever nitric oxide is produced. Meanwhile, inflammatory proteins like COX-2 are heavily upregulated in the endothelial cells themselves. This creates the conditions for atherosclerosis, the buildup of plaque inside artery walls. Atherosclerosis is fundamentally a chronic inflammatory process, and sleep apnea accelerates it through heightened oxidative stress, vascular inflammation, activation of clotting pathways, and direct endothelial damage.
Effects on Fat Tissue and Metabolism
Intermittent hypoxia doesn’t just inflame blood vessels. It also transforms the behavior of visceral fat, the fat stored around your organs. In response to repeated oxygen drops, immune cells called macrophages within fat tissue shift toward a pro-inflammatory state. These activated macrophages release inflammatory signaling molecules that interfere with insulin signaling, contributing to insulin resistance even in people who aren’t obese.
The changes in fat tissue caused by intermittent hypoxia closely mirror what happens in obesity: the same types of inflammatory molecules are released, and the same insulin-signaling pathways are disrupted. This helps explain why type 2 diabetes and glucose intolerance are so common among people with sleep apnea, and why the association persists even after accounting for body weight. Intermittent hypoxia also triggers the release of stress hormones like noradrenaline, which promotes fat breakdown in a way that further impairs insulin sensitivity.
Inflammation in the Brain
The fragmented sleep that comes with sleep apnea also drives inflammation in the brain. In animal studies designed to mimic the sleep disruption of OSA, researchers found that inflammatory markers in brain tissue roughly doubled after four weeks. TNF-alpha concentrations in the brain increased by about 50%, and NF-κB activity nearly doubled. The brain’s resident immune cells, microglia, showed clear signs of activation, particularly around blood vessels.
This neuroinflammation had a direct structural consequence: it damaged the blood-brain barrier, the tightly sealed layer of cells that controls what enters brain tissue from the bloodstream. After four weeks of sleep fragmentation, the blood-brain barrier became about 75% more permeable than normal. The tight junctions between cells showed visible disruption. Most strikingly, the degree of barrier leakiness strongly predicted cognitive performance. Animals with the most permeable barriers performed worst on memory tests, with recognition memory scores dropping from roughly 65% to around 30%. The correlation between barrier integrity and memory was robust, suggesting this is a meaningful pathway through which sleep apnea contributes to cognitive decline.
Can Treatment Reverse the Inflammation?
Treating sleep apnea with CPAP therapy, which keeps the airway open with pressurized air during sleep, does reduce inflammatory markers. Meta-analyses of randomized controlled trials confirm that CPAP lowers CRP, IL-6, and TNF-alpha levels in people with OSA. The research on blood vessel function is even more specific: the reduction in nitric oxide production and the increase in oxidative stress markers both improve with consistent CPAP use, and the degree of improvement tracks with how severe the original oxygen desaturation was.
This reversibility is important because it confirms that sleep apnea itself, not just the obesity or other conditions that often accompany it, is driving the inflammation. When the intermittent hypoxia stops, the inflammatory cascade slows. That said, the improvements depend on consistent use. CPAP works only on the nights you wear it, and the inflammatory pathways reactivate quickly when breathing disruptions return.